Skip to content

8-KAccepted Sep 11, 5:00 PM ET

INTELLIGENT BIO SOLUTIONS Reports Updated Shares Outstanding

INBSINTELLIGENT BIO SOLUTIONS INC.

Accepted (ET)

5:00 PM

Sep 11, 2026

Filed

Sep 11, 2026

Documents

11

Size

197.7 KB

Summary

INTELLIGENT BIO SOLUTIONS Reports Updated Shares Outstanding

Updated

What Happened
INTELLIGENT BIO SOLUTIONS, Inc. (INBS) filed a Form 8-K (Item 8.01) on September 11, 2026 reporting an update to its outstanding common stock. As of the close of business on September 10, 2026, the company reported 3,316,803 shares of common stock outstanding following (a) the exercise of previously disclosed prefunded warrants to purchase 285,000 shares and (b) issuance of 4,333 restricted common shares under the Investor Relations and Corporate Development Advisory Agreement dated February 29, 2024.

Key Details

  • Filing: Form 8-K, Item 8.01, filed September 11, 2026.
  • Shares issued: 285,000 shares from exercised prefunded warrants; 4,333 restricted shares issued.
  • Total outstanding common shares: 3,316,803 as of close of business on September 10, 2026.
  • Net increase: 289,333 shares, roughly a 8.7% portion of the current outstanding share total.

Why It Matters
An updated share count directly affects per‑share metrics (like earnings per share, if applicable), ownership percentage, and voting power. Investors and analysts should use the revised 3,316,803 share figure when updating valuation models, dilution calculations, and any per‑share comparisons. This disclosure is a routine capital‑structure update rather than a change to operations or management.

AI-written summary · check the filing